166 related articles for article (PubMed ID: 15923792)
1. Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
Castagneto B; Zai S; Dongiovanni D; Muzio A; Bretti S; Numico G; Botta M; Sinaccio G
Am J Clin Oncol; 2005 Jun; 28(3):223-6. PubMed ID: 15923792
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.
Kovac V; Zwitter M; Rajer M; Marin A; Debeljak A; Smrdel U; Vrankar M
Anticancer Drugs; 2012 Feb; 23(2):230-8. PubMed ID: 22027538
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Byrne MJ; Davidson JA; Musk AW; Dewar J; van Hazel G; Buck M; de Klerk NH; Robinson BW
J Clin Oncol; 1999 Jan; 17(1):25-30. PubMed ID: 10458214
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.
Favaretto AG; Aversa SM; Paccagnella A; Manzini Vde P; Palmisano V; Oniga F; Stefani M; Rea F; Bortolotti L; Loreggian L; Monfardini S
Cancer; 2003 Jun; 97(11):2791-7. PubMed ID: 12767092
[TBL] [Abstract][Full Text] [Related]
6. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Kalmadi SR; Rankin C; Kraut MJ; Jacobs AD; Petrylak DP; Adelstein DJ; Keohan ML; Taub RN; Borden EC
Lung Cancer; 2008 May; 60(2):259-63. PubMed ID: 18006112
[TBL] [Abstract][Full Text] [Related]
8. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Kindler HL; Karrison TG; Gandara DR; Lu C; Krug LM; Stevenson JP; Jänne PA; Quinn DI; Koczywas MN; Brahmer JR; Albain KS; Taber DA; Armato SG; Vogelzang NJ; Chen HX; Stadler WM; Vokes EE
J Clin Oncol; 2012 Jul; 30(20):2509-15. PubMed ID: 22665541
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H
J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
11. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Pinto C; Marino A; De Pangher Manzini V; Benedetti G; Galetta D; Mazzanti P; Del Conte G; dell'Amore D; Piana E; Giaquinta S; Lopez M; Martoni A
Lung Cancer; 2006 May; 52(2):199-206. PubMed ID: 16542747
[TBL] [Abstract][Full Text] [Related]
12. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM; Baas P; Manegold Ch; Schouwink JH; Burgers JA; de Bruin HG; Mooi WJ; van Klaveren RJ; de Jonge MJ; van Meerbeeck JP
Br J Cancer; 2002 Feb; 86(3):342-5. PubMed ID: 11875695
[TBL] [Abstract][Full Text] [Related]
13. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
Nowak AK; Byrne MJ; Williamson R; Ryan G; Segal A; Fielding D; Mitchell P; Musk AW; Robinson BW
Br J Cancer; 2002 Aug; 87(5):491-6. PubMed ID: 12189542
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.
Tsao AS; Harun N; Lee JJ; Heymach J; Pisters K; Hong WK; Fujimoto J; Wistuba I
Clin Lung Cancer; 2014 May; 15(3):197-201. PubMed ID: 24492162
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.
Portalone L; Antilli A; Nunziati F; Crispino C; de Marinis F; Friggeri L; Lombardi A; Lorusso V; Pronzato P; Sambiasi D; Signora M;
Tumori; 2005; 91(1):15-8. PubMed ID: 15849999
[TBL] [Abstract][Full Text] [Related]
17. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
[TBL] [Abstract][Full Text] [Related]
18. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Okuno SH; Delaune R; Sloan JA; Foster NR; Maurer MJ; Aubry MC; Rowland KM; Soori GS; Nikcevich DA; Kardinal CG; Northfelt DW; Adjei AA;
Cancer; 2008 Apr; 112(8):1772-9. PubMed ID: 18224661
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.
Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A
Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
